MarketInOut Stock Screener Log In | Sign Up

Concord Biotech Ltd

Healthcare • Biotechnology • Quote as of 10/28/2026 15:58
Concord Biotech Ltd stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
Market Capitalization143,879 mln
Float26.84 mln

EPS

29.03
Exceptional

P / E

43.70
High premium

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-2.13
Caution advised

1-Year Forecast

1,552.60
Attractive

Relative Strength

33 / 100
Underperforming

Business Description

Founded in 1984 and headquartered in Ahmedabad, India, Concord Biotech Limited develops and manufactures specialty pharmaceutical ingredients used to treat conditions ranging from organ transplant rejection and cancer to bacterial and fungal infections. The company's products are sold both within India and in international markets, with its manufacturing process centered on fermentation and semi-synthesis techniques. Concord Biotech also partners with other companies to provide contract research and manufacturing services in these same areas.

Key Fundamentals

EPS29.03
P/E43.70
ROE14.46
RPS106
ROIC14.32
ROA12.98
Interest Cover1,202
EBITDA, mln4,366
EV / EBITDA30.31
EV / EBIT36.58
Revenue, mln11,084
EV / Revenue11.94

Quote Details

Last 1,268.50
Change -106.8 (-7.77%)
Open 1,319.90
Volume 380,222
Turnover 482,311,616
Average Volume 109,710

Financial Ratios

Pre-Tax Profit Margin33
Current Ratio7.39
Price / Book6.78
Price / Tangible Book6.78
Price / Cash Flow95.23
Price / Free Cash Flow78.48
Debt / Equity0.00
Price / Sales12.33
PEG Ratio5.41

Financial Strength

Altman Z-Score39.21
Piotroski F-Score 5 / 9
Beneish M-Score-2.13
Price to Lynch Fair Value5.71
Price to Graham Number3.96
1-Year Target Price1,552.60

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -0.12% 64 / 100   
1 Month -12.73% 26 / 100   
2 Months -4% 62 / 100   
6 Months 20.62% 81 / 100   
1 Year -16.65% 48 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog